First Time Loading...

Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 1.5201 USD -3.79%
Updated: May 14, 2024

Trinity Biotech PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Trinity Biotech PLC
Cost of Revenue Peer Comparison

Comparables:
MDT
STE

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Trinity Biotech PLC
NASDAQ:TRIB
Cost of Revenue
-$37.4m
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
2%
Medtronic PLC
NYSE:MDT
Cost of Revenue
-$11.1B
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
STERIS plc
NYSE:STE
Cost of Revenue
-$2.9B
CAGR 3-Years
-18%
CAGR 5-Years
-13%
CAGR 10-Years
-12%

See Also

What is Trinity Biotech PLC's Cost of Revenue?
Cost of Revenue
-37.4m USD

Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Cost of Revenue amounts to -37.4m USD.

What is Trinity Biotech PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
2%

Over the last year, the Cost of Revenue growth was 29%. The average annual Cost of Revenue growth rates for Trinity Biotech PLC have been 11% over the past three years , 8% over the past five years , and 2% over the past ten years .